IQVIA Holdings, Inc. (IQV)
264.97
-6.14
(-2.26%)
USD |
NYSE |
Nov 13, 16:00
264.97
0.00 (0.00%)
After-Hours: 19:59
IQVIA Holdings EPS Diluted (Quarterly) : 2.096 for Sept. 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 2.096 |
| June 30, 2026 | 1.530 |
| March 31, 2026 | 1.614 |
| December 31, 2025 | 2.990 |
| September 30, 2025 | 1.928 |
| June 30, 2025 | 1.536 |
| March 31, 2025 | 1.404 |
| December 31, 2024 | 2.417 |
| September 30, 2024 | 1.547 |
| June 30, 2024 | 1.970 |
| March 31, 2024 | 1.563 |
| December 31, 2023 | 2.545 |
| September 30, 2023 | 1.633 |
| June 30, 2023 | 1.591 |
| March 31, 2023 | 1.532 |
| December 31, 2022 | 1.204 |
| September 30, 2022 | 1.494 |
| June 30, 2022 | 1.340 |
| March 31, 2022 | 1.680 |
| December 31, 2021 | 1.632 |
| September 30, 2021 | 1.336 |
| June 30, 2021 | 0.8979 |
| March 31, 2021 | 1.088 |
| December 31, 2020 | 0.6103 |
| September 30, 2020 | 0.5182 |
| Date | Value |
|---|---|
| June 30, 2020 | -0.1205 |
| March 31, 2020 | 0.419 |
| December 31, 2019 | 0.0812 |
| September 30, 2019 | 0.2864 |
| June 30, 2019 | 0.2991 |
| March 31, 2019 | 0.2876 |
| December 31, 2018 | 0.3381 |
| September 30, 2018 | 0.29 |
| June 30, 2018 | 0.29 |
| March 31, 2018 | 0.3255 |
| December 31, 2017 | 4.795 |
| September 30, 2017 | 0.40 |
| June 30, 2017 | 0.28 |
| March 31, 2017 | 0.43 |
| December 31, 2016 | -0.7454 |
| September 30, 2016 | 0.82 |
| June 30, 2016 | 0.71 |
| March 31, 2016 | 0.88 |
| December 31, 2015 | 0.8488 |
| September 30, 2015 | 0.89 |
| June 30, 2015 | 0.67 |
| March 31, 2015 | 0.68 |
| December 31, 2014 | 0.6875 |
| September 30, 2014 | 0.71 |
| June 30, 2014 | 0.64 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Medpace Holdings, Inc. | 4.845 |
| OmniAb, Inc. | -0.1216 |
| Charles River Laboratories International, Inc. | 6.856 |
| Fortrea Holdings, Inc. | 0.0059 |
| Champions Oncology, Inc. | -0.0306 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 352.00M |
| Revenue (Quarterly) | 4.427B |
| Total Expenses (Quarterly) | 4.077B |
| Enterprise Value | 58.70B |
| Gross Profit Margin (Quarterly) | 26.56% |
| Profit Margin (Quarterly) | 7.95% |
| Earnings Yield | 3.11% |
| Operating Earnings Yield | 5.35% |
| Normalized Earnings Yield | 3.326 |